New Delhi: Ranbaxy Laboratories Ltd has recorded consolidated sales of Rs5,333.3 crore, an 18 per cent growth from last year's Rs4,530.1 crore for the financial year ended December 31, 2004.
Profit before tax stood at Rs973.5 crore compared with last year's Rs1,014.7 crore while net profits stood at Rs743 crore, down from last year's Rs759.4 crore.
For the fourth quarter ended December 31, 2004, the consolidated sales of Ranbaxy and its subsidiaries stood at Rs1,423.5 crore, compared with Rs1,144.4 crore, a growth of 24 per cent.
Profit before tax during the last quarter stood at Rs182.6 crore (Rs246.7 crore) while net profit stood at Rs156.5 crore (Rs175.80 crore).
For the year, the company's global sales grew by 21 per cent. While the US accounted for 36 per cent, Europe and BRIC (Brazil, Russia, India and China) countries constituted 16 per cent and 26 per cent respectively.